Listen to the audio version of this column here:

The history of progress is marked by “inflection points.” Moments when a single technological shift renders the previous era unrecognizable. In 2007, the iPhone did not just upgrade the mobile phone; it condensed the computing, entertainment, music and the entire communication market into a single handheld device, permanently altering how humanity interacts with information.
As we enter 2026, I have been pondering where the biggest changes will occur in this industry – not just in the coming year but in the next decade. I believe that we are at such an inflection point. Eye care is currently standing at its own 2007 moment.
For decades, the delivery of vision care has been a linear, brick-and-mortar affair defined by “the exam.” But as we move toward the 2030s, a convergence of artificial intelligence, decentralized diagnostic hardware and open infrastructure knowledge bases may just fulfill a promise of something previously thought impossible: universal eye care access. To reach this goal within the next decade, we, as individuals and as an industry, must challenge the traditional boundaries of the clinic and embrace the coming evolutionary shift. A shift that will be faster and more disruptive than most providers are prepared for. I foresee five big shifts coming that will lead to this convergence and alter eye care as we know it.
A Patient-Centric Model
The most radical change will be the death of the “episodic visit” as the primary unit of care delivery, as we move from a clinic-centric model to a patient-centric model.
In the next decade, I believe the eye care delivery system will split into a dual-track model. In the first option, there will be virtual triage and autonomous screening. AI-powered “micro-clinics” in pharmacies, primary care offices and even community centers will utilize autonomous fundus cameras and OCT as oculomics hits mainstream medicine. These systems will diagnose diabetic retinopathy, glaucoma, macular degeneration and other forms of neurodegenerative disease with high sensitivity—without an eye doctor present. This in turn will likely lead to a shift of eye care providers from being the primary “screeners” to “interventionists.” The clinic of the next decade will be reserved for complex decision-making, surgical procedures and personalized treatment management.
The Evolving Vision Insurance Model
The second major shift will be an evolution of the vision insurance model. The traditional vision insurance model, built on a “one exam per year” reimbursement structure, is fundamentally incompatible with universal access. To support an AI-driven future, insurance must be willing to embrace the following three trends:
- Outcome-based reimbursement: Imagine a system where providers are paid for prevention of vision loss rather than just the number of refractions performed.
- Diagnostic technologies: There will likely be a new reimbursement model developed for diagnostic technologies, since they will largely be performed outside the specialist’s office. As AI learns to predict disease progression 18–24 months before clinical manifestation, insurers will likely cover “early interventions” that are currently considered elective as a form of predictive coverage.
- Data transparency and liquidity mandate: Currently, electronic health records (EHRs) are the bottleneck of innovation. To hit the goal of universal access, EHRs must evolve from passive digital filing cabinets into active clinical decision support engines. Data will be how practices are valued and services are paid for, so data must be accessible to all and not guarded by each entity. Only by sharing data will the eye care industry progress.
Embracing a New Identity
The fourth major change will be providers and their staff embracing a new identity. Currently, many providers fear that AI will replace us. In reality, AI and AMI (augmented medical intelligence) will liberate us from the mundane and be instrumental in helping more people.
However, this shift requires a painful professional evolution. Providers will shift from the role of “data collector” to “data interpreter.” Providers will spend less time on manual refraction and more time on complex medical and visual management. We have already started seeing the rise of “super-staff.” Technicians, empowered by AI diagnostic tools, will oversee a larger share of the patient volume, allowing the doctor to operate at the absolute “top of their license.”
One word of caution though! Providers who wait for “perfect” peer-reviewed evidence before adopting AI will find themselves in the position of the Blackberry in a world of iPhones—obsolete before they realize the market has moved. Don’t be that person!
Change Starts with the Consumer
The biggest reason for change has already begun and it starts with the consumer. Today’s consumers are “digitally native” and increasingly demanding. They do not want to take half a day off work for a routine check-up. They want frictionless access to care where they are. On top of that, they also want instant results (don’t we all?) instead of waiting two weeks for a specialist to review a scan.
Care will be near real time. It will have to be, or consumers will look for other options and telemedicine will give them those options. We have also already begun the smart device revolution where we consumers are being monitoring by smart watches, phones, HUD’s and soon intravascular, sub epidural and even intraocular diagnostic devices that continuously feed data directly to their AI “health coach.”
The most critical takeaway for the industry is that these technologies will not develop in a vacuum. As AI improves, it will integrate with tele-optometry, 3D printing for bespoke lenses and CRISPR-based gene therapies. When technologies integrate, change is no longer linear; it is exponential. The shift from a fragmented, expensive eye care system to a universal, AI-enabled network will likely happen in half the time the industry expects. The promise of “No Patient Left Behind” is within reach—not because we have more doctors, but because we have finally scaled the doctor’s expertise through the power of the machine.

